Milestone Pharmaceuticals Inc. logo

Milestone Pharmaceuticals Inc.

MIST | NASDAQ
Chart Builder DCF Calculator
$0.92
$0 (+0.46%)
At close: Sep 21, 2026, 4:00 PM ET
$0.92
$0 (-0.24%)
Pre-market: Sep 22, 2026, 4:00 AM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
559K 238K 1.55M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M 3.5M 1.5M n/a n/a n/a n/a 15M n/a
Cost of Revenue
32K 70K n/a 25K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 292K 9.73M n/a n/a
Gross Profit
527K 168K 1.55M -25K n/a n/a n/a n/a n/a n/a n/a n/a n/a 1M 3.5M 1.5M n/a n/a -292K -9.73M 15M n/a
Operating Income
-25.63M -23.77M -17.26M -11.9M -12.53M -20.52M -12.35M -9.62M -9.66M -10.48M -13.8M -15.36M -16.44M -15.5M -13.76M -15.03M -16.81M -14.05M -17M -14.27M 712K -12.59M
Interest Income
1.74M 1.73M 833K 874K 516K 697K 904K 1.08M 1.19M 994K 1.05M 1.12M 1.21M 585K 582K 474K 158K 40K 34K 48K 58K 80K
Pretax Income
-28.61M -26.18M -17.41M -12M -12.97M -20.76M -12.36M -9.44M -9.36M -10.35M -13.61M -15.08M -16.04M -14.95M -13.18M -14.56M -16.65M -14.01M -16.96M -14.23M 770K -12.51M
Net Income
-28.61M -26.07M -17.41M -11.92M -12.97M -20.76M -12.36M -9.44M -9.36M -10.35M -13.61M -15.08M -16.04M -14.95M -13.18M -14.56M -16.65M -14.01M -16.88M -14.23M 770K -12.51M
Selling & General & Admin
22.65M 4.82M 13.28M 7.86M 8.86M 15.55M 8.41M 5.65M 6.85M 6.84M 8.35M 8.64M 7.81M 6.25M 6.19M 6.7M 6.15M 5.28M 5.8M 4.54M 4.86M 4M
Research & Development
3.51M 3.36M 5.52M 4.01M 3.67M 4.98M 3.94M 3.96M 2.82M 3.64M 5.45M 6.72M 8.62M 10.26M 10.71M 9.83M 10.66M 8.77M 10.9M 9.93M 9.51M 8.6M
Other Expenses
n/a 15.76M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 354K n/a n/a n/a n/a -9.93M -87K n/a
Operating Expenses
26.16M 23.94M 18.8M 11.88M 12.53M 20.52M 12.35M 9.62M 9.66M 10.48M 13.8M 15.36M 16.44M 16.5M 17.26M 16.53M 16.81M 14.05M 16.71M 4.54M 14.29M 12.59M
Interest Expense
4.73M 4.14M 985K 967K 951K 935K 919K 903K 887K 872K 857K 841K 820K 33K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a 8.2M 4.63M 5.1M 10.38M 4.41M 1.91M 1.8M 2.88M 4.98M 4.41M 3.37M 2.36M 2.56M 2.67M 2.23M 1.64M n/a 1.58M 1.84M 1.37M
Cost & Expenses
26.19M 24.01M 18.8M 11.9M 12.53M 20.52M 12.35M 9.62M 9.66M 10.48M 13.8M 15.36M 16.44M 16.5M 17.26M 16.53M 16.81M 14.05M 17M 14.27M 14.29M 12.59M
Income Tax Expense
n/a -109K n/a -73K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -80K n/a n/a n/a
Shares Outstanding (Basic)
138.69M 130.29M 83.88M 66.38M 66.38M 66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 41.67M 41.26M
Shares Outstanding (Diluted)
138.69M 130.29M 83.88M 66.38M 66.38M 66.29M 62.21M 66.19M 66.17M 50.16M 33.48M 42.97M 42.94M 42.85M 42.78M 42.49M 42.28M 42.24M 42.18M 42.19M 44.53M 41.26M
EPS (Basic)
-0.21 -0.20 -0.16 -0.12 -0.20 -0.31 -0.20 -0.14 -0.14 -0.21 -0.41 -0.35 -0.37 -0.35 -0.31 -0.33 -0.39 -0.33 -0.40 -0.34 0.02 -0.30
EPS (Diluted)
-0.21 -0.20 -0.16 -0.12 -0.20 -0.31 -0.20 -0.14 -0.14 -0.21 -0.41 -0.35 -0.37 -0.35 -0.31 -0.33 -0.39 -0.33 -0.40 -0.34 0.02 -0.30
EBITDA
-23.83M -21.98M -16.39M -11M -11.99M -19.8M -11.42M -8.51M -8.45M -9.45M -12.73M -14.22M -15.2M -14.9M -13.16M -14.53M -16.62M -13.98M -16.67M -14.2M 793K -12.57M
EBIT
-23.89M -22.04M -16.42M -11.03M -12.02M -19.83M -11.44M -8.54M -8.48M -9.48M -12.75M -14.24M -15.22M -14.92M -13.18M -14.56M -16.65M -14.01M -16.96M -14.23M 770K -12.59M
Depreciation & Amortization
57K 56K 34K 25K 28K 27K 26K 25K 26K 28K 26K 24K 24K 18K 15K 27K 24K 23K 292K 24K 23K 23K

© 2026 bestshares.com. All rights reserved.